The Neutrino Donut has been listed as a service provider for SBIR consulting under the Department of Energy website. Other Syndicate members, Rare Innovation and Venture Craft, have been noted as well.
The Neutrino Donut continues to expand our customer base. We have entered into agreements with multiple states and their respective agencies, universities, and economic development groups to provide commercialization and grant services to startups. Recent trips to Pennsylvania, Texas, and Nebraska and other locations have opened new opportunities for the company. We have ongoing relationships with other states and organizations.
The Neutrino Donut is reviewing technologies for the Japanese university. These technologies are groundbreaking ideas from international organizations. Our goal is to understand markets for these technologies outside of Japan and potential US and EU market entry.
The Syndicate is an affiliated group of consultants with extensive work in the area of technology commercialization, grant programs, and development services. The Neutrino Donut works with these organizations to provide extended services and support to our clients.
Members of The Syndicate have demonstrated industry experience in the commercialization of science technologies, have a deep understanding of product development, and have successfully developed a business in this space. Within this group, we have expertise with multiple technology areas, government agency grant programs, and academic processes and programs.
Project Leader, The Syndicate
Earle Hager is the Managing Partner of The Neutrino Donut, a consultancy focused on the management and commercialization of science. He has managed strategic planning for company growth, customer management, and all aspects of business development processes. His specific target areas include biotech, healthcare, consumer goods, chemistry, IT, materials science, environmental, product innovation, strategic planning, and development of business development strategies.
As part of this consultancy, he has completed over 300 technology assessments and over 200 business development projects in innovative technologies over the last ten for domestic and international clients. Mr. Hager has also been part of many SBIR commercialization projects, writing multiple commercialization sections and consulting on many more. These projects include grant reviews for DoE, DoD, NIH, NSF, and other agencies as well as US and foreign universities, marketing and business development for multiple universities, SBIR grant development, and running multiple startups.
He is also a member of two grant review panels with NIH and DoD. His international experience includes projects in Hungary, Japan, India, Korea, Mexico, Portugal, Chile, Ukraine, Russia, Viet Nam, Qatar, and other countries. The Donut in the name of the company stands for the Direct Observation of the Neutrino Tau.
B.S., Economics, The Wharton School, University of Pennsylvania
Tim Raines specializes in Business Development, Commercialization, Marketing and Sales for complex science and technology ideas and innovations. He is experienced in domestic and international commercialization, with international work predominantly for foreign technologies seeking to commercialize within the US. He has worked with technologies in the batteries, engines, business and commercialization plans, IP protection, grant writing, business development, sales, marketing, and branding with emphasis on physical sciences in energy, optics, software, healthcare, and defense. [EC1]
He has a strong grasp of highly complex science and technology concepts with the ability to distill them into concise and executable marketing strategy.
He has worked with projects with the DOE, NIST, NIH, DOD and has provided services in grant support, follow-on bizdev, review panelist for DoD CDMRP (healthcare), and PI for DOE Phase I, Plasma Facing Components. Globally, he serves science and tech innovators, institutions, and policy makers in developing economies, and has experience working with groups in India, Mexico, Hungary, Columbia, Ukraine, Qatar, Korea, and more.
Texas McCombs School of Business, MS, Science and Technology Commercialization
Shaun Sanders is the Managing Partner of VentureCraft, Inc., and a startup veteran with more than 15 years of experience building and growing companies (early stage to Series A) across numerous markets. His consulting practice is largely industry-agnostic as he has provided commercialization and business guidance to clients across multiple sectors, including: energy, agriculture, SaaS, blockchain and fintech, biotech and Medtech, entertainment, and consumer goods. Sanders is a Professor of Law at USC Gould.
Between 2011 and 2013, Sanders worked with multiple Y Combinator portfolio companies, including Reddit, Hipmunk, inDinero, and AirBNB, while developing and managing cross-branded marketing campaigns with Google, Angry Birds, and SXSW. In 2014, Sanders managed the creation of the Angel Syndication Network, one of the largest angel investment syndication groups in the country that tied together resources and members from more than a dozen investment groups. Later, he joined in building out the startup-focused Applied Innovation at the University of California, Irvine. In 2016, Sanders joined HOTB, a software development company with an investment arm that handled more than $6 billion in program assistance on behalf of the U.S. Treasury and more than 14 state agencies. There, Sanders acted as Corporate Counsel, overseeing the company’s RFP program, negotiating terms between startups and investors, and developing strategic operational initiatives. In 2021, Sanders was brought on by the Australian government to assist the surrounding Asia Pacific countries hit hardest by COVID-19 and provide business and legal guidance to startups in Fiji, Samoa, Cambodia, and Myanmar.
At his core, Sanders is an educator with a talent for breaking down complicated ideas and abstract goals into articulable, scalable milestones. To date, he has assisted hundreds of entrepreneurs and startups in growing early-stage ideas into scalable, commercialized successes that have raised hundreds of millions of dollars in capital.
Juris Doctor, Chapman University Dales E. Fowler School of Law
B.S. Business Administration and Human Resource, California State University, Dominguez Hills
California State Bar, licensed but inactive.
Member, The Syndicate
For the past decade, Ben has been working in the entrepreneurship and commercialization space to cultivate his passion for new technology development. His experience includes managing licensing & campus technology transfer at a Tier 1 research university, instructing as an adjunct professor of entrepreneurship, serving as a grant reviewer, and even being entrepreneur himself by founding two tech companies of his own.
Today, Ben runs Bennovative Consulting whose purpose is to help catalyze early stage technologies from concept to commercialization. Through this work, Ben has worked with many different types of technologies of varying complexity such as new software applications, nuclear fusion, nuclear storage, EVs & their batteries, many environmental materials, renewable energies, medical devices, drug discovery, and agricultural tech. In addition, this work led to collaborative interactions with many agencies and organizations such as the DOE, NIH, USDA, and the CDMRP program.
To date, Ben has reviewed 300+ technologies and counseled 80+ companies. Licensing strategies, business development, product roadmaps, and go-to-market strategies are included in his specialties.
M.S. Civil & Environmental Engineering The University of Alabama
MBA, Manderson Graduate School of Business, The University of Alabama
Chris Coburn specializes in technology commercialization utilizing federal grants. His current work includes DOE grant commercialization planning for several thermodynamic and reactor instrumentation products. His services are customer-centric and fit any high-tech commercialization or product development needs. They include customer identification, market research, business plan development, customer value proposition, supported by decades of experience that The Syndicate provides for any aspect of technology commercialization.
He brings to the table more than thirty years of study and engineering of internal combustion engines and expertise in highly complex assemblies and processes such as transmissions, hydraulics, test methods, high-speed video and instrumentation, and root cause failure analysis. He also has experience in explosive weapons technology development with previous DOD clearance, and bird strike testing on military and civilian aircraft.
Chris’s proven management and current-production skills include business case development, product development and launch, product line management, and financial planning and analysis. His team management skills and methods include team creation, mentoring, empowerment, engagement, development, goal tracking and cross-functional team building.
University of Wisconsin-Madison, MEPP, Master of Engineering in Professional Practice
Old Dominion University, Bachelor’s, Mechanical Engineering
Dr. Emilie Clemmens specialties include grant writing, peer review, biomedical sciences and engineering. She has been working for 25 years in biomedical sciences and engineering, 5+ years in peer review management, and one year as grant writer. She has worked with many commercialization plans, including 13 grants in the first year of business, and managed 40-50 peer review panels as a Scientific Review Officer (grant review management) with CDRMP at DoD. She also serves as an Adjunct Assistant Professor in Biomedical Engineering at the University of Kentucky.
As a grant writer and reviewer, her focus is providing high level services based on her extensive expertise in peer review, grants management, and strong background in the sciences.
Michael Zarrabian is with Concept IP | LLP, The Intellectual Property Law Firm for Innovators. He is a registered patent attorney and hi-tech engineer. He focuses on intellectual property law for hi-tech, manufacturing and business sectors. He works closely with clients on patents, trademarks, copyrights, and counseling for all IP matters.
He works with start-ups to emerging and mid-size companies in manufacturing and business sectors for consumer electronics, apps, software, hardware, cloud, e-commerce, electrical, mechanical, medical, optics, apparel, appliances, etc. He also worked with companies in the tech sector in software, AI, hardware, electronics, manufacturing, emerging companies, start-ups, Internet, e-commerce, and the like.
Bachelor of Science in Electrical/Computer Engineering and Computer Science (minor in Mechanical and Electromechanical Systems) from the University of California, Los Angeles, magna cum laude.
Master of Science, Computer Engineering, University of Southern California
J.D., Loyola Law School
Member of California Bar
Member of United States Patent & Trademark Office Bar
The Neutrino Donut is working with several startups in the development of their commercialization grant process. In the Phase 1 grant program, we are helping them develop their Phase 2 commercialization process. In our work, the commercialization process involves developing a strategy for market entry, identifying customers, and understanding the extent of an engagement.
Hard times are forcing biopharma companies to extend their runways as they try to eke out every cent of value from their capital. This goes beyond conserving cash and prioritizing programs, affecting how they consider their opportunities.
The approach companies take depends upon their size. “At smaller companies, success depends on being able to generate positive data and thus attract investors,” Lance Minor, principal and life sciences national co-leader at BDO, told BioSpace. “If tightening the belt means focusing resources on getting to that next clinical readout, that’s an appropriate approach.”
In contrast, he continued, “With mid-sized companies, prioritizing their pipeline to meet earnings projections or better manage cash probably has a lower overall impact on the company and its stock price.”
Although some companies are delaying launches, “Extending the runway doesn’t necessarily mean slowing down,” Minor stressed. Instead, it may mean shepherding resources by narrowing clinical trials to focus on fewer indications rather than targeting multiple disease types simultaneously.
Analysts say financing options are likely to remain constrained for the remainder of this year.
At this point, we are waiting for Congress to approve the advancement of the SBIR process. As expected, the politics is a major aspect of the stall and possible limitation of the approval process.
The larger change, a movement toward local support services, rather than nationwide contractors, is major shift in the management of SBIR processes.
In order to be successful, SBIR consulting partners will need to develop local relationships with key players and startups. This will involve more time spent understanding specific challenges by different group and creating the relationships with local and national partners.
The extent of your network will determine the future of your consulting services. The network is not only your clients, but also the contacts you can bring to a relationship.
The Neutrino Donut prides ourselves with our ability to create relationships with our clients and customize our services based on the needs of our clients. The flexibility to offer services or provide local partners to consulting engagements is key to this process.
The Neutrino Donut prides ourselves on the extent of our ability to provide corporate introductions for our clients in a variety of industries and contact points. Our network is massive and these relationships are key. We manage these contacts by providing targeted technology introductions and ensure the focus is on the technologies and startups of interest.
The SBIR world is changing. But, sales has always been about relationships. And coffee’s for closers only.
The Neutrino Donut, LLC has joined Life Sciences PA. Life Sciences Pennsylvania’s mission is to ensure Pennsylvania is the United States hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.
The Donut will be attending their October event, Life Sciences Future, BioPharm. We will also be in Pittsburgh for their BioSciences breakfast.
The Neutrino Donut is expanding our reach of customers and partners as part of an aggressive growth strategy to manage changes in the SBIR processes.
For many investigators, particularly those in biomedical research and technology, funding opportunities at the Department of Defense are a bit of a “black box”–less well understood and shrouded in myths such as “only for warfare equipment” or “must benefit those in Service”. The truth is that a large number of funding opportunities are available from the DoD that cover a surprisingly wide range of research areas and are available for myriad investigators, from entrepreneurs and junior investigators to established investigators and foundation directors. In this talk, we will shine some light on available funding from the DoD. Leveraging our years of experience navigating several of these opportunities, we aim to help individuals and institutions identify relevant DoD funding mechanisms and share some wisdom gleaned on how to succeed in winning their agreements and contracts. Webinar is provided in partnership with University of Kentucky Office of Technology Commercialization.
Managing Partner @Neutrino Donut
Mr. Hager is the Managing Partner of The Neutrino Donut (Direct Observation of the Neutrino Tau), a consultancy focused on the management and commercialization of science. He has managed strategic planning for company growth, customer management, and business development aspects. His specific target areas include biotech, healthcare, consumer goods, chemistry, IT, materials science, environmental, product innovation, strategic planning, and development of business development strategies. Mr. Hager has worked with corporate R&D groups introducing products, completed over 300 technology assessments and over 200 business development projects in innovative technologies, and also been part of many SBIR commercialization projects, writing multiple commercialization sections and consulting on many more. Projects include grant reviews for DoE, DoD, NIH, NSF, as well as US and foreign universities, SBIR grant development, and running multiple startups.